ABSTRACT Pretreatment of mouse L cells with mouse interferon (IFN) inhibits the penetration of vesicular stomatitis virus without affecting viral adsorption. The inhibition of virus uptake by IFN is dose dependent and, at the highest dose tested (1,000 units/ml), reaches 65%; 24 hr of treatment with IFN are required for maximal effect. A (2) (3) (4) (5) . Because several studies showed that IFN pretreatment can inhibit replication of infectious viral RNA but does not alter the ability of virus to adsorb to host cells, it has been assumed that IFN has no effect on the ability of virus to enter cells (6) (7) (8) (9) (10) (11) (12) .
It has been generally accepted that in cells pretreated with interferon (IFN), virus growth is blocked at the level of gene expression (reviewed in ref. 1 ). In addition, there is evidence that IFN may block the maturation and release of certain viruses (2) (3) (4) (5) . Because several studies showed that IFN pretreatment can inhibit replication of infectious viral RNA but does not alter the ability of virus to adsorb to host cells, it has been assumed that IFN has no effect on the ability of virus to enter cells (6) (7) (8) (9) (10) (11) (12) .
Virus uptake by animal cells is a two-step process: (i) adsorption of the virus to the cell surface, a temperature-independent function, and (ii) penetration or internalization of the virus, which occurs only at physiological temperatures (13, 14) . It is known that some viruses carry out this second step by direct fusion of the virus and cell membranes, whereas other viruses are internalized by endocytosis (15) (16) (17) (18) .
In the course of studies on the effect of virus infection on endocytosis, we found that IFN inhibited endocytosis by cells, as measured by the uptake ofa fluid-phase marker enzyme, horseradish peroxidase (unpublished results). Because endocytosis is believed to be the mechanism of penetration for many viruses, we tested the effect of IFN on the entry of vesicular stomatitis virus (VSV) into host cells and found that pretreatment of cells with IFN resulted in a marked inhibition of the uptake of VSV. fibroblasts were cultivated at 37°C in 95% air/5% CO2 in Eagle's minimal essential medium supplemented with 4% calf serum and 100 units of penicillin and 100 ,ug of streptomycin per ml (19) . Human diploid fibroblasts were obtained from John Armstrong (University of Pittsburgh) and were cultivated in the same manner as chicken fibroblasts except that 4% fetal calf serum was used.
Stocks of VSV (Indiana strain) were grown in baby hamster kidney BHK-21 cells as described (20) . Plaque assays of VSV infectivity were done in primary chicken embryo fibroblasts.
IFN. Crude mouse IFN (16,000 units/ml) was prepared in L cells infected with Newcastle disease virus as described (21 (20) .
35S-Labeled VSV purified in this manner had a titer of 4.2 X 101l plaque-forming units (pfu)/ml, a specific activity of 6.5 x 109 cpm/ml, and a pfu/particle ratio of 0.06. When this preparation was examined by NaDodSO4/polyacrylamide gel electrophoresis, only the five VSV proteins were detected (see Fig.  2 ).
Virus Penetration. Monolayer cultures of L cells in 35-mm dishes (3-6 x 105 cells) were incubated for 60 min at 37°C with 0.5 ml of complete medium containing 3S-labeled virus at the multiplicity of infection (moi) indicated, usually 5 . In each experiment, an equal number of mock-treated and IFN-treated cells were infected. After incubation, the inoculum was removed and the cells were washed twice with 1 ml of Hepes/ saline (10 mM Hepes, pH 7.2/150 mM NaCl). Then the monolayer was incubated with 1 ml of standard trypsin/EDTA (0.25% trypsin (Difco)/0.025% EDTA in phosphate-buffered saline) for 7 min at room temperature to remove virus adsorbed to the cell surface. To terminate the trypsin treatment, 1 ml of Hepes/saline containing 10% calf serum was added, the cells were harvested and centrifuged at 2,000 rpm for 5 min in an International model PR-2 centrifuge (rotor 269). The pellet was washed once with 1 ml of Hepes/saline/10% calf serum, and the final pellet was solubilized in 1 ml of Hepes/saline containing 0.5% NaDodSO4. The radioactivity in the cell extract was determined by liquid scintillation counting. The protein concentrations of the final solubilized cell pellets were determined by the method of Lowry et al. (23) . The solubilized cell pellets of mock-treated and IFN-treated cells did not differ significantly in their-protein concentrations. The amount of radioactive virus taken up by cells was expressed as counts per min per mg of protein.
Abbreviations: IFN, interferon; VSV, vesicular stomatitis virus; moi, multiplicity of infection; pfu, plaque-forming unit. P Virus Adsorption. L-cell monolayers were precooled to 40C for 15 min, infected with 'S-labeled VSV at a moi of 5, and incubated for 60 min at 40C. Unadsorbed virus was removed by three washes with Hepes/saline precooled to 40C, and the cells were solubilized in Hepes/saline/0.5% NaDodSO4. The amount of cell-associated radioactivity was determined by liquid scintillation counting. Protein was determined in each sample, and all values for radioactivity were normalized to a protein concentration of 1 mg/ml. At least 99% of the radioactive virus that was cell-associated under these conditions was sensitive to removal by trypsin treatment.
RESULTS
The Effect of IFN on.VSV Penetration. In order to test the effect of IFN on VSV penetration, L-cell monolayers were pretreated for 24 hr at 370C with 1,000 units of crude mouse IFN. The IFN-containing medium was removed, and the cells were infected with purified 3S-labeled VSV (moi, 5). At the indicated times after the addition of virus, the amount of trypsin-insensitive 35S-labeled VSV associated with the cell was determined. IFN pretreatment of L cells significantly reduced the rate of virus uptake as compared to mock-treated cells (Fig. 1) . At the end of 2 hr of incubation with virus, the control cells had internalized 12.2% of radioactive virus contained in the inoculum, and the IFN-treated cells had taken up only 5 .0% of the inoculum.
The radioactive virus that was cell-associated after trypsin treatment was examined by NaDodSO4/polyacrylamide gel electrophoresis. A normal complement of the five VSV proteins was internalized by both control and IFN-treated cells (Fig. 2,  lanes 2 and 3) . The IFN-mediated inhibition of virus uptake was dose dependent (Fig. 3 ). Cells were mock-treated or treated with purified or crude IFN (1-1,000 units/ml) for 24 hr at 37°C. Although IFN at 1 unit/ml had no effect, at 10 units/ml it inhibited virus uptake by 7% and at 1,000 units/ml it inhibited virus penetration by >65%. This dose-response was similar to the level of inhibition observed when fluid-phase endocytosis was mea- 20. After 60 min of incubation at 37°C, the trypsin-insensitive cell-associated radioactivity was prepared and analyzed by NaDodSO4/polyacrylamide gel electrophoresis by the method of Laemmli (24) as modified by Lesnaw (25) (26) .
Induction and Decay of IFN-Mediated Inhibition of Viral Penetration. The full expression of IFN-mediated inhibition of VSV penetration required several hours of IFN treatment (Fig.  4) . Maximal inhibition was observed after 24 hr of treatment with 1,000 units of IFN per ml at 370C. The kinetics of induction of this effect are similar to the kinetics of development of the antiviral state in L cells (1) . However, a direct kinetic comparison is complicated by the fact that virus uptake is measured over a short time period (1 hr), whereas measurement of the antiviral state requires a complete virus growth cycle. It is difficult to establish whether or not the IFN-induced inhibition of VSV penetration requires de novo host cell gene expression, because inhibitors of host macromolecular synthesis such as cycloheximide or actinomycin D also inhibit endocytosis after 6- virus that was cell-associated after 1 hr at 370C was determined. The control value representing maximum (100%) virus uptake was 6,100 cpm per mg of cell protein.
hr of treatment (unpublished observation).
In order to study the decay of the IFN effecton virus uptake, monolayer cultures of L cells were treated with crude mouse IFN at 1,000 units/ml for 24 hr at 37TC. The IFN-containing medium was removed and replaced with fresh medium. The uptake of 'S-labeled VSV was determined at 24-hr intervals.
Removal of the IFN from cells resulted in a decay of the inhibition of virus uptake (Fig. 5) DISCUSSION Although the IFN-induced antiviral response is known to be multifaceted, it has been thought that IFN had no effect on the virus growth cycle at the level of penetration (1, 6, (10) (11) (12) . The data in this paper show that IFN treatment markedly reduces the penetration of VSV into cells without affecting the adsorption of virus to the cell surface. The effect of IFN on viral penetration is dose dependent, and the kinetics of induction and decay of the IFN-mediated inhibition of uptake are similar to those observed for the induction and decay of the IFN-mediated antiviral response (1) . The inhibition of VSV penetration by IFN is species specific and requires homologous IFN in mouse, human, and avian cells.
The substantial reduction of virus entry after IFN treatment could explain the inhibitory effect of IFN on early events in viral infection, such as primary transcription by VSV (27, 28) . The observation that IFN reduces the amount of simian virus 40 DNA that enters the nuclei of infected cells (29) also may result from a reduced rate of virus uptake.
Because IFN inhibits endocytosis, it might be predicted that penetration of all viruses that enter the cell through endocytosis may be inhibited similarly. It will be of particular interest to determine if IFN can inhibit the uptake of viruses that enter the cell by direct membrane fusion rather than by endocytosis (18) .
Beside antiviral effects, IFN is known to inhibit the growth of many other intracellular parasites, including Rickettsiae, some species of bacteria, and protozoa (30) . Compared to the inhibition of virus, a much higher dose (10-to 100-fold) of IFN is needed to inhibit these infectious agents (31) . These dose levels are similar to those shown here to inhibit virus uptake. Because endocytosis is known to be the mode of entry for many of these intracellular parasites (32) (33) (34) , the IFN-mediated inhibition of endocytosis may be responsible, at least in part, for the inhibitory effects of IFN. Compared to other known antiviral effects of IFN (e.g., inhibition of translation of viral proteins), the inhibition of virus penetration is somewhat less dramatic and probably only serves as a first line of defense. It requires comparatively high doses of IFN, but those dose levels are well within physiological limits. In the vicinity of IFN-producing cells in vivo, local IFN concentrations have been calculated to be as high as 107 units/ml (35) . Although viral uptake is only partially blocked by IFN treatment, at low multiplicities of infection this level of inhibition could protect a significant proportion of a cell population from infection.
